发明名称 |
Composition comprising alpha-1,2 fucosyl glycans for treating gastrointestinal disorders |
摘要 |
<p>An individual at risk for necrotizing enterocolitis and related disorders can be identified by measuring the level of at least one secretor antigen in a biological sample from the individual and comparing the measured level of the at least one secretor antigen to a predetermined value or a predetermined range of values. Among the secretor antigens which can be measured are: the H-1, H-2, Lewisb and Lewisy antigens and derivatives thereof (e.g., a sialylated form of Lewis a, Lewis x, Lewis b, Lewis y; H-1, H-2, Lewis a, Lewis x, Lewis b or Lewis y).</p> |
申请公布号 |
EP2631650(A1) |
申请公布日期 |
2013.08.28 |
申请号 |
EP20130169236 |
申请日期 |
2008.09.05 |
申请人 |
CHILDREN'S HOSPITAL MEDICAL CENTER;THE GENERAL HOSPITAL CORPORATION;INSTITUTO NACIONAL DE CIENCIAS MEDICAS Y NUTRICION |
发明人 |
MORROW, ARDYTHE L.;RUIZ-PALACIOS, GUILLERMO M.;NEWBURG, DAVID S. |
分类号 |
G01N33/53;A23L1/29;A23L1/30;G01N33/68;G01N33/80 |
主分类号 |
G01N33/53 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|